NCT06378138 2025-11-21ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)Beijing InnoCare Pharma Tech Co., Ltd.Phase 2/3 Recruiting226 enrolled
NCT03818334 2019-02-01Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesHospital Israelita Albert EinsteinPhase 2/3 Recruiting50 enrolled